3 Pharmacy Chain, Personal Care Ingredient and Edible Oil Brand Stocks With a Strong Future Roadmap: Medplus Health Services, Galaxy Surfactants and AWL Agri Business

Pharmacy chain, personal care ingredient and edible oil brand stocks give investors exposure to medicines, personal care ingredients and kitchen staples bought every day. Volumes, store additions and margins decide how much of that demand turns into profit.

This list covers three pharmacy chain, personal care ingredient and edible oil brand stocks: Medplus Health Services for a pharmacy retail chain with stores across several states, Galaxy Surfactants for surfactants and specialty ingredients for personal care and home care brands and AWL Agri Business for edible oils, packaged foods and staples sold under the Fortune brand. Every figure comes from the latest reported financials and the 14 October 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

What Are Pharmacy Chain, Personal Care Ingredient and Edible Oil Brand Stocks?

Pharmacy chain, personal care ingredient and edible oil brand stocks are shares of companies that make health products, chemicals or run restaurants. Results depend on volumes, store additions and margins, so margins and cash flow separate the stronger names.

Pharmacy Chain, Personal Care Ingredient and Edible Oil Brand Stocks at a Glance

The table compares size, valuation, return on equity and debt for the three pharmacy chain, personal care ingredient and edible oil brand stocks as of the 14 Oct 2026 close.

Among healthcare, chemicals and consumer stocks, all three trade at a discount to their industry P/E multiples.

Why Do Pharmacy Chain, Personal Care Ingredient and Edible Oil Brand Stocks Have a Strong Roadmap in India?

Pharmacy chain, personal care ingredient and edible oil brand stocks have a strong roadmap in India because pharmacy store additions, personal care brand volumes and household food spending keep adding volumes for these firms. Three drivers stand out.

• Pharmacy reach: New stores bring medicines closer to homes.
• Personal care: Brands buy surfactants for soaps and shampoos.
• Kitchen staples: Families buy edible oils and packaged foods.

Medplus Health Services: Pharmacy Retail Stores Anchor the Roadmap

Medplus' roadmap rests on a pharmacy retail chain with stores across several states, with store expansion supporting revenue.

Revenue grew from Rs 3,810.64 crore in FY22 to Rs 6,963.79 crore in FY26, an 82.7% rise, and FY26 revenue was 12.6% higher than FY25. FY26 net profit rose 46.2% to Rs 219.61 crore. Over four years, net profit rose from Rs 94.72 crore in FY22 to Rs 219.61 crore. In Q1 FY27, revenue grew 21.9% to Rs 1,899.43 crore. Operating margin was 9.85% in FY26.

Debt to equity is 0.72 and return on equity is 11.12%. FY26 operating cash flow was Rs 495.58 crore against capital expenditure of Rs 123.03 crore. At a P/E of 36.06 against an industry P/E of 66.59, the stock trades below its industry multiple.

What to watch: Net profit margin is only 3.2%, so small cost changes move earnings.

Galaxy Surfactants: Personal Care Ingredients Anchor the Roadmap

Galaxy Surfactants' roadmap rests on surfactants and specialty ingredients for personal care and home care brands, with global consumer companies as customers supporting volumes.

Revenue grew from Rs 3,698.22 crore in FY22 to Rs 5,279.92 crore in FY26, a 42.8% rise, and FY26 revenue was 24.2% higher than FY25. FY26 net profit was Rs 267.38 crore. In Q1 FY27, revenue grew 38.5% to Rs 1,785.18 crore. Operating margin was 9.25% in FY26 and 14.17% in Q1 FY27 against 10.57% a year earlier.

Debt to equity is 0.09 and return on equity is 9.74%. FY26 operating cash flow was Rs 332.66 crore against capital expenditure of Rs 136.95 crore. Galaxy Surfactants paid a dividend of Rs 22 per share for FY26, a yield of 0.91%. At a P/E of 24.09 against an industry P/E of 36.60, the stock trades below its industry multiple.

What to watch: Q1 FY27 operating margin was 14.17% against 9.25% for FY26, so margin stability is the figure to follow as volumes grow.

AWL Agri Business: Edible Oils and Staples Build the Next Leg

AWL Agri's roadmap rests on edible oils, packaged foods and staples sold under the Fortune brand, with a wide distribution network supporting volumes.

Revenue grew from Rs 54,327.16 crore in FY22 to Rs 75,148.47 crore in FY26, a 38.3% rise, and FY26 revenue was 17.6% higher than FY25. FY26 net profit was Rs 990.44 crore. In Q1 FY27, revenue grew 16.5% to Rs 20,116.91 crore, and net profit rose 47.7% to Rs 351.39 crore. Operating margin was 3.38% in FY26 and 3.90% in Q1 FY27 against 3.39% a year earlier.

Debt to equity is 0.11 and return on equity is 9.98%. FY26 operating cash flow was Rs 3,928.34 crore against capital expenditure of Rs 833.37 crore. AWL Agri paid a dividend of Rs 1 per share for FY26, a yield of 0.55%. At a P/E of 20.49 against an industry P/E of 34.85, the stock trades below its industry multiple.

What to watch: Net profit margin is only 1.3%, so small cost changes move earnings.

Best Pharmacy Chain, Personal Care Ingredient and Edible Oil Brand Stocks in India: Medplus vs Galaxy Surfactants vs AWL Agri on Key Financials

Among the best pharmacy chain, personal care ingredient and edible oil brand stocks in India, Medplus leads on FY26 operating margin and return on equity; Galaxy Surfactants leads on FY26 revenue growth and Q1 FY27 revenue growth; AWL Agri leads on the lowest P/E. The table puts the numbers side by side.

Healthcare, chemicals and food earnings follow volumes, store additions and margins, so full-year numbers and quarterly trends together give a better view.

How to Evaluate Pharmacy Chain, Personal Care Ingredient and Edible Oil Brand Stocks to Buy Before You Invest

A short checklist keeps the research consistent when you screen pharmacy chain, personal care ingredient and edible oil brand stocks and shortlist pharmacy chain, personal care ingredient and edible oil brand stocks to buy.

1. Compare each stock's P/E with its industry P/E, which differs by company here.
2. Check revenue growth, operating margin and cash flow together.
3. Check whether revenue growth is turning into profit growth, not only sales.
4. Read operating cash flow against capital expenditure to see how growth is funded.
5. Watch debt to equity and interest cover before sizing a position.
6. Spread exposure across companies and business lines instead of one demand cycle.

Check the Univest Screener for live data on these pharmacy chain, personal care ingredient and edible oil brand stocks

Risks to Consider Before Investing in Pharmacy Chain, Personal Care Ingredient and Edible Oil Brand Stocks

• Consumer demand: Spending patterns can shift sales between quarters.
• Input costs: Changes in raw material prices can affect margins.
• Quarterly trends: A single weak quarter can change near-term earnings, so track results every quarter.

Download the Univest iOS App or Univest Android App to track Medplus, Galaxy Surfactants and AWL Agri live.

Final Take: Which Stock Has the Strongest Roadmap?

These three healthcare, chemicals and consumer stocks cover pharmacies, personal care ingredients and edible oils. Medplus leads on FY26 operating margin and return on equity; Galaxy Surfactants leads on FY26 revenue growth and Q1 FY27 revenue growth; AWL Agri leads on the lowest P/E.

Across pharmacy chain, personal care ingredient and edible oil brand stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the pharmacy chain, personal care ingredient and edible oil brand stocks to buy discussed here.

FAQs on Pharmacy Chain, Personal Care Ingredient and Edible Oil Brand Stocks

Which are the best pharmacy chain, personal care ingredient and edible oil brand stocks in India with a strong roadmap?

Ans. Medplus Health Services, Galaxy Surfactants and AWL Agri Business stand out for their roadmaps in pharmacies, personal care ingredients and edible oils. FY26 revenue growth was 12.6% at Medplus, 24.2% at Galaxy Surfactants and 17.6% at AWL Agri, and return on equity ranges from 9.74% to 11.12%.

Is Medplus Health Services a good stock to buy now?

Ans. Medplus Health Services has a debt to equity ratio of 0.72, a return on equity of 11.12% and a P/E of 36.06 against an industry P/E of 66.59. Valuation, demand and input costs move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.

What is the P/E ratio of Medplus, Galaxy Surfactants and AWL Agri?

Ans. The P/E ratio is 36.06 for Medplus (industry 66.59), 24.09 for Galaxy Surfactants (industry 36.60) and 20.49 for AWL Agri (industry 34.85). All of them trade below the industry multiple.

Which of these pharmacy chain, personal care ingredient and edible oil brand stocks has the highest return on equity?

Ans. Medplus Health Services has the highest return on equity at 11.12%, followed by AWL Agri Business at 9.98% and Galaxy Surfactants at 9.74%.

What are the risks of investing in pharmacy chain, personal care ingredient and edible oil brand stocks?

Ans. The main risks are consumer demand, input costs and quarterly trends. Spending patterns can shift sales between quarters.

How did Medplus, Galaxy Surfactants and AWL Agri perform in Q1 FY27?

Ans. Medplus Health Services reported revenue of Rs 1,899.43 crore, up 21.9% year on year. Galaxy Surfactants reported revenue of Rs 1,785.18 crore, up 38.5% year on year. AWL Agri Business reported revenue of Rs 20,116.91 crore, up 16.5% year on year, and net profit rose 47.7% to Rs 351.39 crore.

Do pharmacy chain, personal care ingredient and edible oil brand stocks pay dividends?

Ans. Galaxy Surfactants and AWL Agri pay dividends. The dividend yield is 0.91% for Galaxy Surfactants and 0.55% for AWL Agri, based on dividends declared for FY26.

How can I invest in pharmacy chain, personal care ingredient and edible oil brand stocks in India?

Ans. You can buy pharmacy chain, personal care ingredient and edible oil brand stocks through a demat and trading account on NSE or BSE after checking each company's financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.